Barriers in the management of glucocorticoid-induced osteoporosis
- PMID: 17266078
- DOI: 10.1002/art.22462
Barriers in the management of glucocorticoid-induced osteoporosis
Abstract
Objective: To determine present practice for the management of glucocorticoid-induced osteoporosis (GIOP) in veterans; to characterize provider knowledge, beliefs, and practice behaviors regarding management of GIOP; and to identify potential barriers and interventions in the management of GIOP.
Methods: To characterize current management of GIOP in an academic veterans administration medical center, we conducted a retrospective chart review of 100 patients who were prescribed a 90-day supply of prednisone. To assess clinicians' knowledge of GIOP clinical guidelines and perceptions of GIOP management, primary care clinicians and subspecialists completed a questionnaire and participated in focus groups.
Results: Chart review revealed that only 32 of 100 patients receiving long-term glucocorticoid treatment underwent bone mineral density testing, and only 32 patients were prescribed the recommended calcium supplements. Of the 23 providers who completed the questionnaire and participated in the focus groups, 4 correctly identified both the dose and duration of glucocorticoid use at which GIOP prevention measures should be instituted. Common GIOP management barriers cited by participants were lack of knowledge, having limited time during the clinic visit to address all problems, patient nonadherence, and system problems. The most commonly mentioned potential interventions were the use of computerized clinical reminders and patient education.
Conclusion: Clinicians frequently do not follow recommended guidelines for the management of GIOP. Improving the management of GIOP will likely require a fundamental redesigning of care processes for this disorder in order to overcome provider, patient-related, and system barriers.
Similar articles
-
Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.Arthritis Rheum. 2002 Dec;46(12):3136-42. doi: 10.1002/art.10613. Arthritis Rheum. 2002. PMID: 12483716
-
Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.J Clin Rheumatol. 2006 Oct;12(5):221-5. doi: 10.1097/01.rhu.0000242778.65766.22. J Clin Rheumatol. 2006. PMID: 17023807
-
Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.Arthritis Rheum. 2006 Dec 15;55(6):873-7. doi: 10.1002/art.22350. Arthritis Rheum. 2006. PMID: 17139663
-
[Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].Clin Calcium. 2010 May;20(5):645-53. Clin Calcium. 2010. PMID: 20445275 Review. Japanese.
-
Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science.Semin Arthritis Rheum. 2005 Aug;35(1):1-4. doi: 10.1016/j.semarthrit.2005.03.006. Semin Arthritis Rheum. 2005. PMID: 16084217 Review.
Cited by
-
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.Front Endocrinol (Lausanne). 2022 Jun 9;13:908727. doi: 10.3389/fendo.2022.908727. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35757436 Free PMC article. Review.
-
Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover.Int J Mol Sci. 2022 Jan 25;23(3):1376. doi: 10.3390/ijms23031376. Int J Mol Sci. 2022. PMID: 35163300 Free PMC article. Review.
-
Understanding and Managing Corticosteroid-Induced Osteoporosis.Open Access Rheumatol. 2021 Jul 2;13:177-190. doi: 10.2147/OARRR.S282606. eCollection 2021. Open Access Rheumatol. 2021. PMID: 34239333 Free PMC article. Review.
-
Glucocorticoid-induced osteoporosis.RMD Open. 2015 Apr 8;1(1):e000014. doi: 10.1136/rmdopen-2014-000014. eCollection 2015. RMD Open. 2015. PMID: 26509049 Free PMC article. Review.
-
Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis.PLoS One. 2013 Dec 6;8(12):e80890. doi: 10.1371/journal.pone.0080890. eCollection 2013. PLoS One. 2013. PMID: 24324644 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical